InvestorsHub Logo

Barron4664

11/03/20 12:13 PM

#331457 RE: sunspotter #331440

Sunspotter, for years your central thesis about CTIX then IPIX was that you were here to warn all of us retail investors that this was a garden variety OTC penny stock scam. Have you changed your position on IPIX now that you are commenting on clinical trials? If so, welcome.

BonelessCat

11/03/20 12:46 PM

#331465 RE: sunspotter #331440

The likely protocol is to add Brilacidin to Remdesivir as treatment. It would be unethical have an unproven drug go against any standard of care along with a placebo group. Brilacidin has tested as a combination with Remdesivir, so the grouping would be Remdesivir plus B and Remdesivir plus placebo. The R
+ B group would then have an escalation for only B to find optimization. The outcomes would then look for increased efficacy over R alone. Remdesivir has such a low benefit over no treatment that increased benefit is a very low bar.